Assura PLC
LSE:AGR
Assura PLC
Cash & Cash Equivalents
Assura PLC
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Assura PLC
LSE:AGR
|
Cash & Cash Equivalents
£58.9m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
Primary Health Properties PLC
LSE:PHP
|
Cash & Cash Equivalents
£3.2m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-10%
|
|
Target Healthcare REIT PLC
LSE:THRL
|
Cash & Cash Equivalents
£17.6m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Impact Healthcare REIT PLC
LSE:IHR
|
Cash & Cash Equivalents
£9.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
L
|
Life Science REIT PLC
LSE:LABS
|
Cash & Cash Equivalents
£14.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Assura PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
58.9m
GBP
Based on the financial report for Sep 30, 2023, Assura PLC's Cash & Cash Equivalents amounts to 58.9m GBP.
What is Assura PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-10%
Over the last year, the Cash & Cash Equivalents growth was -63%. The average annual Cash & Cash Equivalents growth rates for Assura PLC have been -43% over the past three years , -10% over the past five years .